title: Salmeterol (Serevent) asthma trial halted early.
authors.forename: Eric
authors.initials: E
authors.lastname: Wooltorton
mesh_terms: D000318:Adrenergic beta-Agonists / Q000009:adverse effects*; D000420:Albuterol / Q000009:adverse effects* / Q000031:analogs & derivatives*; D018927:Anti-Asthmatic Agents / Q000009:adverse effects*; D001249:Asthma / Q000139:chemically induced* / Q000188:drug therapy* / Q000208:ethnology / Q000401:mortality; D044383:Black People; D006801:Humans; D015337:Multicenter Studies as Topic; D000068299:Salmeterol Xinafoate; D016896:Treatment Outcome; D044465:White People
chemical_list: D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D000068299:Salmeterol Xinafoate; D000420:Albuterol